REVErsing Airway Remodelling With Tezepelumab
NCT05651841
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Airway Remodelling, Asthmatic
Interventions
DRUG:
Tezepelumab
OTHER:
placebo
Sponsor
University Hospital, Montpellier